Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up

Ad

Investor Relations

MASI Stock - Masimo Corporation Stock Trading


home / stock / masi

MASI MASI Quote MASI Short MASI News MASI Articles MASI Message Board

MWN AI Summary *

Masimo Corporation (NASDAQ: MASI) is an innovative medical technology company known for its advanced non-invasive monitoring technologies. Founded in 1989 and headquartered in Irvine, California, Masimo focuses on developing instruments and noninvasive monitoring solutions that significantly enhance patient safety and improve health outcomes. The company specializes in pulse oximetry, which measures the oxygen saturation levels of a patient’s blood, a critical parameter in medical monitoring.

Masimo’s flagship product, the SET® pulse oximetry technology, is recognized for its accuracy and reliability, particularly in challenging conditions such as low perfusion and motion. This technology has reshaped the standard of care in hospitals, expanding its applications across various clinical settings. Moreover, the company has introduced a suite of innovative products, including the Rainbow® Pulse CO-Oximetry technology, which extends the capabilities of traditional monitoring by providing additional parameters like hemoglobin levels and carbon monoxide levels noninvasively.

In recent years, Masimo has pursued strategic expansion, diversifying its offerings beyond pulse oximetry. The company has ventured into areas such as tetherless monitoring solutions and wearable technology, notably with the acquisitions of CET technology and the launch of products aimed at home health and remote patient monitoring—which have gained traction, particularly during and after the COVID-19 pandemic.

Financially, Masimo has shown robust growth, consistently reporting strong revenues and expanding its market presence globally. However, the company operates in a competitive landscape, facing challenges from both established players and startups in the medical device arena.

As healthcare increasingly shifts toward outpatient and remote monitoring, Masimo’s innovations position it as a key player in the future of patient care, making it a company to watch in the evolving healthcare technology landscape.

MWN AI Analysis *

As of October 2023, Masimo Corporation (NASDAQ: MASI) operates as a leading innovator in medical technology, particularly in noninvasive monitoring. Known for its pioneering work in pulse oximetry, the company has expanded its product suite to include advanced noninvasive monitors that provide real-time data on various physiological parameters. Investors examining Masimo's market position should take into account several key factors.

Firstly, Masimo’s strong focus on research and development underscores its commitment to innovation, which remains a critical growth driver in the competitive healthcare market. The introduction of new products, such as its noninvasive hemoglobin and carbon dioxide monitors, could significantly enhance the company’s value proposition in hospitals and other healthcare settings.

Financially, Masimo has demonstrated resilience, with a history of solid revenue growth. Investors should keep an eye on the company's quarterly earnings reports, which provide insights into product demand and geographical market performance. Watch for trends in gross margins, as well, since maintaining or improving profit margins amid inflationary pressures in healthcare can indicate operational efficiency.

However, potential investors must also be cautious. The medical technology sector faces regulatory scrutiny, and any delays or challenges in product approvals can adversely affect stock performance. Additionally, competition from other medical device companies may pressure pricing and market share.

From a technical perspective, reviewing recent stock performance, Masimo shares have shown volatility characteristic of growth-oriented stocks. The stock’s performance needs careful monitoring; bullish signals, such as strong volume in upward price movements, can suggest positive sentiment. Conversely, any significant downturns should be analyzed to understand underlying risks.

In conclusion, while Masimo Corporation presents a compelling investment opportunity within the innovative medical technology space, careful consideration of market conditions, competitive landscape, and regulatory environment is essential for prospective investors. Maintain a balanced approach to assess risks alongside potential rewards.

* MWN AI Summary and Analysis is based on asking OpenAI to summarize and analyze the company and stock symbol.


About | Masimo Corporation (NASDAQ:MASI)

Masimo is an Irvine, California-based medical device business that focuses on noninvasive patient monitoring. It began by developing superior signal processing algorithms to measure blood oxygenation levels through pulse oximetry and has expanded this expertise into a wide range of measurements and applications. The company generates revenue globally, with the United States the largest market (67% of 2020 sales), followed by Europe, the Middle East, and Africa (21%), Asia and Australia (9%), and North and South America excluding the U.S. (3%).

Quote | Masimo Corporation (NASDAQ:MASI)

Last:$166.32
Change Percent: -0.44%
Open:$166.14
Close:$166.32
High:$168.81
Low:$165.59
Volume:356,274
Last Trade Date Time:07/10/2025 03:40:06 pm

News | Masimo Corporation (NASDAQ:MASI)

  • Masimo Joins Innovators' Network at American Heart Association Center for Health Technology & Innovation

    American Heart Association Consortium Advances Development of Evidence-based Health Tech Solutions Masimo (NASDAQ: MASI), a global medical technology company that develops and manufactures innovative noninvasive monitoring solutions, has joined the American Heart Association Cente...

    • July 08, 2025 08:00:00 am

    • |
    • Business Wire
    • |
      • MASI Stock
      • MASI Quote
      • MASI Short
      • MASI News
      • MASI Articles
      • MASI Message Board
  • Masimo Corporation: A Much Cleaner Picture

    2025-06-23 17:35:08 ET Towards the end of last year, I called Masimo Corporation ( MASI ) a stellar performer after the dust settled. A proxy fight and acquisition of Sound United have caused a real overhang on the business in recent years, but with both items being on the v...

    • June 23, 2025 05:35:08 pm

    • |
    • SeekingAlpha
    • |
      • MASI Stock
      • MASI Quote
      • MASI Short
      • MASI News
      • MASI Articles
      • MASI Message Board

Message Board Posts | Masimo Corporation (NASDAQ:MASI)

Subject By Source When
whytestocks: $MASI News Article - Masimo and Philips Expand Partnership to Improve Telehealth for Pa whytestocks investorshangout 01/18/2023 6:40:46 PM
whytestocks: $MASI News Article - Masimo Takes Major Step in Connecting the Hospital to the Home whytestocks investorshangout 12/13/2022 7:35:56 PM
whytestocks: $MASI News Article - Masimo Hosts Investor Day to Detail Next Phase of Its Growth Traje whytestocks investorshangout 12/13/2022 7:15:48 PM
whytestocks: $MASI News Article - Federal Court Rules for Masimo in Suit Against Former Engineer for whytestocks investorshangout 11/17/2022 4:40:52 PM
whytestocks: $MASI News Article - Masimo (MASI) Q1 2022 Earnings Call Transcript whytestocks investorshangout 05/04/2022 3:05:51 PM

MWN AI FAQ **

What are the key growth drivers for Masimo Corporation (NASDAQ: MASI) in terms of product innovation and market expansion over the next few years?

Masimo Corporation's key growth drivers include its innovative noninvasive monitoring technologies, expansion into international markets, strategic partnerships with healthcare providers, and increasing demand for remote patient monitoring solutions in response to telehealth trends.

How does Masimo Corporation (NASDAQ: MASI) plan to enhance its competitive position amidst the increasing scrutiny and competition in the medical technology sector?

Masimo Corporation (NASDAQ: MASI) aims to enhance its competitive position in the medical technology sector by innovating its non-invasive monitoring technologies, expanding its product portfolio, and strengthening strategic partnerships to meet rising healthcare demands.

Can Masimo Corporation (NASDAQ: MASI) maintain its profit margins in light of rising manufacturing costs and potential regulatory challenges?

Masimo Corporation (NASDAQ: MASI) may face challenges in maintaining profit margins due to rising manufacturing costs and potential regulatory hurdles, but strategic pricing, operational efficiency, and innovation could help mitigate these pressures.

What are the implications of recent partnerships or acquisitions for Masimo Corporation (NASDAQ: MASI) in strengthening its market presence?

Recent partnerships and acquisitions by Masimo Corporation (NASDAQ: MASI) enhance its market presence by broadening its product offerings, expanding its technological capabilities, and increasing its access to new customer segments, ultimately driving growth and competitiveness.

** MWN AI Questions are based on asking OpenAI to ask and answer four questions about the company and stock symbol.

Stock Information

Get MASI Alerts

News, Short Squeeze, Breakout and More Instantly...

Masimo Corporation Company Name:

MASI Stock Symbol:

NASDAQ Market:

-0.44% G/L:

$166.32 Last:

356,274 Volume:

$166.14 Open:

$166.32 Close:

Masimo Corporation Website:

Masimo Corporation Logo

Ad

Investor Relations
RECENT MASI NEWS
  • MASI - Masimo Joins Innovators' Network at American Heart Association Center for Health Technology & Innovation

    American Heart Association Consortium Advances Development of Evidence-based Health Tech Solutions Masimo (NASDAQ: MASI), a global medical technology company that develops and manufactures innovative noninvasive monitoring solutions, has joined the American Heart Association Cente...

  • MASI - New Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric Anesthesia

    EEG-Guided Anesthesia Using Masimo Technology Significantly Reduced Pediatric Anesthesia Emergence Delirium, Time to Emergence and Discharge, and Cost of Care by Minimizing Sevoflurane Exposure Masimo (NASDAQ: MASI) today announced the findings of a randomized clinical trial publi...

  • MASI - Masimo to Present in the Jefferies Global Healthcare Conference

    Masimo (NASDAQ: MASI) today announced that its management will participate in the Jefferies Global Healthcare Conference on Wednesday, June 4, 2025 at 1:25 p.m. Eastern time. A live webcast of the presentation will be available on the Masimo website at www.masimo.com . A replay of the webca...

  • Research
  • Stock Search
  • News Releases
  • Articles
  • Topics
  • Message Boards
  • Trending Stocks
  • Trending Feed
  • Trending Alerts
  • Watchlist
  • Short Information
  • Stock Wall
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Link your X Account

Link your X Account to Market Wire News

When you linking your X Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your X account.

Be alerted of any news about your stocks and see what other stocks are trending.



Connect with Us

Join our Telegram Alerts Channel

Telegram

Join our Discord

Discord

Get MASI Alerts

Get MASI Alerts

News, Short Squeeze, Breakout and More Instantly...

Sign up or login to continue

Sign up or login to continue.


Forgot password?




Mobile Number Subscribers

Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

How to Opt Out

To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

Mobile Support

For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email support@marketwirenews.com.


Disclaimer

This electronic content is for the purposes of solicitation subscriptions for Market Wire News. Market Wire News expects to generate new advertisement revenue resulting from the distribution of this electronic content. The amount of which is unknown at this time. Market Wire News is not a registered investment adviser or broker-dealer. This electronic content does not provide a professional analysis of a any stock financial position. any stock's financial position and all other information regarding the featured Company should be verified directly with any stock. This electronic content is provided as an information service only, and any statements and opinions in this electronic content should not be construed as an offer or solicitation to buy or sell any security. Market Wire News accepts no liability for any loss arising from an investor's reliance on or use of this electronic content. An investment in any company is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Market Wire News does not own, buy, sell or plans to own, buy, sell, and of any stock's shares. This electronic content contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Please read our full disclaimer for compensation and more detailed information.

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Log In

Sign Up

Stay Connected

| X

| Facebook

| BlueSky

| LinkedIn

| Telegram

| Discord


Contact

Privacy

Terms of Service

Disclaimer

© 2025 Market Wire News 1